Expansion of Cell Processing and Storage Capacity
First written in FY2021. 13 of 19 entries say "Advanced", first in FY2022-Q1. Latest entry: 2026-08-06.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Construction of the CPC (Cell Processing Center) and CCC (Cell Storage Center), equipped with the latest facilities, is currently progressing smoothly, and the application for a business license to Singapore's Ministry of Health (MOH) has been completed.」
Construction of the CPC and CCC in Singapore is progressing, and the business license application has been completed. The planned completion date under the equipment plan is June 2026. - FY2026-H1AdvancedAnnual report
「To open a Cell Processing Center (CPC), we have completed the lease agreement for the property and are proceeding with equipment design, while preparing an application for approval from Singapore's Ministry of Health (MOH), which is required to commence operations. The CPC is scheduled to begin operations and the business is scheduled to commence in the first quarter of the fiscal year ending March 2027.」
The company completed the lease agreement for the CPC property in Singapore and proceeded to equipment design and preparations for an MOH approval application. The planned timing for the start of operations and business was also stated as the first quarter of the fiscal year ending March 2027. - FY2025AdvancedAnnual report
「The third Cell Storage Center was completed as of March 2025 and commenced operations in May 2025. As a result, storage capacity was expanded from approximately 140,000 to approximately 200,000 specimens, based on umbilical cord blood storage.」
Completion and commencement of operations at the third Cell Storage Center expanded storage capacity from approximately 140,000 to approximately 200,000 specimens. In addition, the company acquired land in Yokohama in February 2025 and is proceeding with plans to construct a future cell processing and storage center. - FY2024-Q1AdvancedAnnual report
「The company is steadily strengthening operations, including adding administrative offices, at the Yokohama Cell Processing Center and Second Storage Center, which began operations in 2021 and can handle three times the previous scale, in preparation for future growth in the number of specimens and further business expansion.」
The company is strengthening operations at the Yokohama Cell Processing Center and the second storage center, which can handle a scale three times the previous level, including by expanding the management office. - FY2023RestatedAnnual report
「The operating structure of the Yokohama Cell Processing Center, which obtained a license to manufacture specified processed cells from the Ministry of Health, Labour and Welfare's Kanto-Shinetsu Regional Bureau on 12 March 2021 and commenced operations, is progressing smoothly. We are working to secure annual processing capacity of approximately 20,000 specimens, a medium-term management target, and to strengthen operating capabilities.」
The company continues to strengthen the Yokohama Cell Processing Center's annual processing capacity of approximately 20,000 specimens and operating capabilities. The securing of annual capacity of approximately 20,000 specimens had already been reported in the previous filing. - FY2023-Q3AdvancedAnnual report
「The company is also making steady progress in strengthening the operations of the Yokohama Cell Processing Center, which obtained a manufacturing license for specified cell-processing products from the Ministry of Health, Labour and Welfare’s Kanto-Shinetsu Regional Bureau of Health and Welfare on 12 March 2021 and began operating. It has already secured annual processing capacity for approximately 20,000 samples, about three times the previous capacity, which is its medium-term target.」
It was stated that the Yokohama Cell Processing Center's operating structure had been strengthened and that it had secured annual processing capacity of approximately 20,000 specimens, approximately three times the previous level, in line with its medium-term target. - FY2023-Q1RestatedAnnual report
「In anticipation of an increase in the number of specimens, we are strengthening operations at the Yokohama Cell Processing Center and the second storage center, which began operating last year and can handle a scale three times the previous level, thereby preparing for further business growth.」
The company continues to strengthen operations at the Yokohama Cell Processing Center and the second storage center, which can handle a scale three times the previous level, following the start of operations. The commencement of operations itself had already been reported in the previous filing. - FY2022AdvancedAnnual report
「In anticipation of an increase in the number of specimens, we began operating the Yokohama Cell Processing Center and the second storage center during the current fiscal year, both capable of handling a scale three times the previous level, thereby preparing for further business growth.」
The Yokohama Cell Processing Center and the second storage center commenced operations, increasing processing capacity to approximately three times the previous level and storage capacity from approximately 70,000 to approximately 140,000 specimens. - FY2022-Q3AdvancedAnnual report
「The company has already established a cell processing center capable of handling a scale three times the current level.」
It was newly stated that the company has established a cell processing center capable of handling a scale three times the current level. - FY2022-Q2RestatedAnnual report
「In preparation for a sharp increase in the number of specimens after the COVID-19 pandemic subsides, we are also strengthening the operating systems of the Yokohama Cell Processing Center, opened in March of this year, and the second Cell Storage Center, opened in June.」
The company continues to strengthen the operating systems of the Yokohama Cell Processing Center and the second Cell Storage Center following their opening. The opening of the facilities themselves had already been reported by the previous quarter. - FY2022-Q1AdvancedAnnual report
「In preparation for an increase in the number of specimens, we opened the Yokohama Cell Processing Center in March of this year and the second Cell Storage Center in June, thereby expanding cell processing and storage capacity.」
Following the Yokohama Cell Processing Center, the company opened the second Cell Storage Center in June 2021. Expansion of processing and storage capacity advanced through the development of specific facilities. - FY2021First statedAnnual report
「In March 2021, we opened a cell processing center in Yokohama to improve cell processing capacity in preparation for future growth in demand for umbilical cord blood and to launch a new business, an umbilical cord (umbilical tissue) storage service.」
The opening of the Yokohama Cell Processing Center was expected to approximately double umbilical cord blood processing capacity. The opening of the second cell storage facility was expected to expand storage capacity from approximately 70,000 to approximately 140,000 specimens.